Manufacturers Eye Challenges Of Broadening Cell And Gene Therapy Access
Potential Expansion From Academia To Community
With more advanced therapies gaining approval, companies at ARM’s Cell and Gene Meeting on the Mesa considered hurdles to making their products more broadly available and developing them for larger indications.
